Heart Attack Diagnostics Market By Type (Electrocardiogram, Blood Tests, Angiogram, Computerized Cardiac Tomography, Others), By End User (Hospitals, Diagnostics Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Heart Attack Diagnostics Market
The heart attack diagnostics market was valued at $9.2 billion in 2023 and is projected to reach $21.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.
Heart attack diagnostic comprises of diagnosing the blood pressure, temperature, and pulse rate of a patient. A series of evaluations are conducted to determine if an individual has experienced a heart attack, also known as myocardial infarction. The series of diagnostic tests includes an electrocardiogram (EKG) which measures the electrical activity of heart, blood tests to detect cardiac enzymes such as troponin which are released into the bloodstream in case of heart muscle damage, and imaging tests such as coronary angiography or echocardiography for the visualization of heart & its blood vessels.
Increase in sedentary lifestyles has led to surge in occurrence of lifestyle diseases, including heart attack. This has led to surge in demand for heart attack diagnostics, hence augmenting the growth of the market. Furthermore, exponential growth in the geriatric population globally is opening avenues for the expansion of the market. The assimilation of AI in the EKG testing is poised to become mainstream in the future as it reduces the diagnosis time. A hospital in Taiwan conducted research regarding the assimilation of AI and EKG, which reduced the diagnosis period by 10 minutes. Constant improvements in AI are enhancing the efficacy of clinical decision support system, encouraging medical practitioners to adopt the technology.
However, these diagnostics tests are extremely expensive and prevent several end users from leveraging their benefits, hence restraining the market development. In addition, the introduction of new diagnostic technologies is subject to various regulatory hurdles, hence presenting challenges for the expansion of the market. Different regulatory bodies such as the U.S. Food and Drug Administration, European Medicines Agency, the Pharmaceuticals and Medical Devices Agency in Japan, and Central Drugs Standard Control Organization in India have mandated the adherence to their respective regulatory guidelines for the entry of new diagnostic technologies into the market. Contrarily, innovative techniques being introduced into the market are an indicator of its promising future. For instance, Siemens Healthineers, a German healthcare company, has introduced a handheld device which claims to detect heart attack in less than 30 minutes. The launch of such devices is expected to quicken treatment delivery and increase the chances of recovery for patients in the future.
Segment Review
The heart attack diagnostics market is segmented into type, end user, and region. On the basis of type, the market is divided into electrocardiogram, blood tests, angiogram, computerized cardiac tomography, and others. By end user, it is classified into hospitals, diagnostics centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
The major players operating in the global heart attack diagnostics market include Bionet Co., Ltd, TOSHIBA CORPORATION, Bio-Rad Laboratories Inc, Life Sign LLC, Schiller AG, Beckman Coulter,Inc., GE Healthcare, Hitachi Medical Systems, F. Hoffmann-La Roche Ltd., and Abbott Laboratories. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Type
Electrocardiogram
Blood Tests
Angiogram
Computerized Cardiac Tomography
Others
By End User
Hospitals
Diagnostics Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Bionet Co., Ltd
TOSHIBA CORPORATION
Bio-Rad Laboratories Inc
Life Sign LLC
Schiller AG
Beckman Coulter,Inc.
GE Healthcare
Hitachi Medical Systems
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- CHAPTER 4: HEART ATTACK DIAGNOSTICS MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Electrocardiogram
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Blood Tests
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Angiogram
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Computerized Cardiac Tomography
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.6. Others
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
- CHAPTER 5: HEART ATTACK DIAGNOSTICS MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospitals
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Diagnostics Centers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: HEART ATTACK DIAGNOSTICS MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Heart Attack Diagnostics Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Heart Attack Diagnostics Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Heart Attack Diagnostics Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Heart Attack Diagnostics Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. Germany Heart Attack Diagnostics Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. Italy Heart Attack Diagnostics Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Spain Heart Attack Diagnostics Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. UK Heart Attack Diagnostics Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Heart Attack Diagnostics Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Heart Attack Diagnostics Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. Japan Heart Attack Diagnostics Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Heart Attack Diagnostics Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. South Korea Heart Attack Diagnostics Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. Australia Heart Attack Diagnostics Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Heart Attack Diagnostics Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Heart Attack Diagnostics Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. South Africa Heart Attack Diagnostics Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. Saudi Arabia Heart Attack Diagnostics Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Heart Attack Diagnostics Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By End User
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. Bionet Co., Ltd
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. TOSHIBA CORPORATION
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Bio-Rad Laboratories Inc
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Life Sign LLC
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Schiller AG
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Beckman Coulter, Inc.
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. GE Healthcare
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Hitachi Medical Systems
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. F. Hoffmann-La Roche Ltd.
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Abbott Laboratories
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. HEART ATTACK DIAGNOSTICS MARKET FOR ELECTROCARDIOGRAM, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. HEART ATTACK DIAGNOSTICS MARKET FOR BLOOD TESTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. HEART ATTACK DIAGNOSTICS MARKET FOR ANGIOGRAM, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. HEART ATTACK DIAGNOSTICS MARKET FOR COMPUTERIZED CARDIAC TOMOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 8. HEART ATTACK DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. HEART ATTACK DIAGNOSTICS MARKET FOR DIAGNOSTICS CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. HEART ATTACK DIAGNOSTICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 13. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 15. U.S. HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 16. U.S. HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 17. CANADA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 18. CANADA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. MEXICO HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 20. MEXICO HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 21. EUROPE HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 22. EUROPE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. EUROPE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 24. FRANCE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 25. FRANCE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. GERMANY HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. GERMANY HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. ITALY HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 29. ITALY HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 30. SPAIN HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 31. SPAIN HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. UK HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 33. UK HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 34. REST OF EUROPE HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 35. REST OF EUROPE HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 37. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 38. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. CHINA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. CHINA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. JAPAN HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 42. JAPAN HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 43. INDIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 44. INDIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. SOUTH KOREA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 46. SOUTH KOREA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. AUSTRALIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 48. AUSTRALIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF ASIA-PACIFIC HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. LAMEA HEART ATTACK DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 52. LAMEA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 53. LAMEA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. BRAZIL HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. BRAZIL HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 56. SOUTH AFRICA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 57. SOUTH AFRICA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. SAUDI ARABIA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 59. SAUDI ARABIA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. REST OF LAMEA HEART ATTACK DIAGNOSTICS, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 61. REST OF LAMEA HEART ATTACK DIAGNOSTICS, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 62. BIONET CO., LTD: KEY EXECUTIVES
- TABLE 63. BIONET CO., LTD: COMPANY SNAPSHOT
- TABLE 64. BIONET CO., LTD: OPERATING SEGMENTS
- TABLE 65. BIONET CO., LTD: PRODUCT PORTFOLIO
- TABLE 66. BIONET CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 67. TOSHIBA CORPORATION: KEY EXECUTIVES
- TABLE 68. TOSHIBA CORPORATION: COMPANY SNAPSHOT
- TABLE 69. TOSHIBA CORPORATION: OPERATING SEGMENTS
- TABLE 70. TOSHIBA CORPORATION: PRODUCT PORTFOLIO
- TABLE 71. TOSHIBA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 72. BIO-RAD LABORATORIES INC: KEY EXECUTIVES
- TABLE 73. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
- TABLE 74. BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
- TABLE 75. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
- TABLE 76. BIO-RAD LABORATORIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 77. LIFE SIGN LLC: KEY EXECUTIVES
- TABLE 78. LIFE SIGN LLC: COMPANY SNAPSHOT
- TABLE 79. LIFE SIGN LLC: OPERATING SEGMENTS
- TABLE 80. LIFE SIGN LLC: PRODUCT PORTFOLIO
- TABLE 81. LIFE SIGN LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 82. SCHILLER AG: KEY EXECUTIVES
- TABLE 83. SCHILLER AG: COMPANY SNAPSHOT
- TABLE 84. SCHILLER AG: OPERATING SEGMENTS
- TABLE 85. SCHILLER AG: PRODUCT PORTFOLIO
- TABLE 86. SCHILLER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 87. BECKMAN COULTER, INC.: KEY EXECUTIVES
- TABLE 88. BECKMAN COULTER, INC.: COMPANY SNAPSHOT
- TABLE 89. BECKMAN COULTER, INC.: OPERATING SEGMENTS
- TABLE 90. BECKMAN COULTER, INC.: PRODUCT PORTFOLIO
- TABLE 91. BECKMAN COULTER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 92. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 93. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 94. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 95. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 96. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97. HITACHI MEDICAL SYSTEMS: KEY EXECUTIVES
- TABLE 98. HITACHI MEDICAL SYSTEMS: COMPANY SNAPSHOT
- TABLE 99. HITACHI MEDICAL SYSTEMS: OPERATING SEGMENTS
- TABLE 100. HITACHI MEDICAL SYSTEMS: PRODUCT PORTFOLIO
- TABLE 101. HITACHI MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 103. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 104. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
- TABLE 105. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 106. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 108. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 109. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 110. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 111. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION
- FIGURE 2. GLOBAL HEART ATTACK DIAGNOSTICS MARKET
- FIGURE 3. SEGMENTATION HEART ATTACK DIAGNOSTICS MARKET
- FIGURE 4. TOP INVESTMENT POCKET IN HEART ATTACK DIAGNOSTICS MARKET
- FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 8. LOW THREAT OF SUBSTITUTION
- FIGURE 9. HIGH COMPETITIVE RIVALRY
- FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHEART ATTACK DIAGNOSTICS MARKET
- FIGURE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION, BY TYPE
- FIGURE 12. HEART ATTACK DIAGNOSTICS MARKET FOR ELECTROCARDIOGRAM, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. HEART ATTACK DIAGNOSTICS MARKET FOR BLOOD TESTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. HEART ATTACK DIAGNOSTICS MARKET FOR ANGIOGRAM, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. HEART ATTACK DIAGNOSTICS MARKET FOR COMPUTERIZED CARDIAC TOMOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION, BY END USER
- FIGURE 18. HEART ATTACK DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. HEART ATTACK DIAGNOSTICS MARKET FOR DIAGNOSTICS CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. HEART ATTACK DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 25. COMPETITIVE DASHBOARD
- FIGURE 26. COMPETITIVE HEATMAP: HEART ATTACK DIAGNOSTICS MARKET
- FIGURE 27. TOP PLAYER POSITIONING, 2023
- FIGURE 28. BIONET CO., LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 29. BIONET CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. BIONET CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. TOSHIBA CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. TOSHIBA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. TOSHIBA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. BIO-RAD LABORATORIES INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. LIFE SIGN LLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. LIFE SIGN LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. LIFE SIGN LLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. SCHILLER AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. SCHILLER AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. SCHILLER AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. BECKMAN COULTER, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. BECKMAN COULTER, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. BECKMAN COULTER, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. HITACHI MEDICAL SYSTEMS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. HITACHI MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. HITACHI MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook